Colombatto, P.; Demirtas, C.O.; Ricco, G.; Civitano, L.; Boraschi, P.; Scalise, P.; Cavallone, D.; Oliveri, F.; Romagnoli, V.; Bleve, P.;
et al. Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. Cancers 2021, 13, 2064.
https://doi.org/10.3390/cancers13092064
AMA Style
Colombatto P, Demirtas CO, Ricco G, Civitano L, Boraschi P, Scalise P, Cavallone D, Oliveri F, Romagnoli V, Bleve P,
et al. Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. Cancers. 2021; 13(9):2064.
https://doi.org/10.3390/cancers13092064
Chicago/Turabian Style
Colombatto, Piero, Coskun Ozer Demirtas, Gabriele Ricco, Luigi Civitano, Piero Boraschi, Paola Scalise, Daniela Cavallone, Filippo Oliveri, Veronica Romagnoli, Patrizia Bleve,
and et al. 2021. "Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib" Cancers 13, no. 9: 2064.
https://doi.org/10.3390/cancers13092064
APA Style
Colombatto, P., Demirtas, C. O., Ricco, G., Civitano, L., Boraschi, P., Scalise, P., Cavallone, D., Oliveri, F., Romagnoli, V., Bleve, P., Coco, B., Salvati, A., Urbani, L., Bonino, F., & Brunetto, M. R.
(2021). Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. Cancers, 13(9), 2064.
https://doi.org/10.3390/cancers13092064
